Patent · US Active

Human plasma kallikrein inhibitors

US10329260B2 · kind B2 · utility

15Cited by
3References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2018
Grant dateJun 25, 2019
Priority date—
Expiry dateMay 11, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.